ASND, GDS, ADSK and CDZI among after hours movers
9.63BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04351P1012
CUSIP
04351P101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-3.14
Dividend Share
-
Dividend Yield
-
Earnings Share
-6.53
Wall Street Target Price
223.78
EPS Estimate Current Year
-4.24
EPS Estimate Next Year
2.25
EPS Estimate Current Quarter
-1.5055
EPS Estimate Next Quarter
-1.2749
Most Recent Quarter
-
Revenue TTM
368,700,992
Gross Profit TTM
314,495,008
EBITDA
-328,827,008
Profit Margin
-92.67%
Return On Assets TTM
-22.39%
Return On Equity TTM
-818.43%
Revenue Per Share TTM
6.284
Qtly Revenue Growth YOY
5.30%
Diluted Eps TTM
-6.53
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
26.7178
Price Book MRQ
14.5547
Enterprise Value Revenue
24
Enterprise Value EBITDA
-20
305.50
4.27%90.81
2.85%179.39
2.07%562.00
0.00%491.50
-18.72%152.16
-8.23%573.26
-1.34%441.89
-1.17%244.01
-1.16%79.76
-0.01%